In the first results to emerge from HIV patient trials of a new generation of so-called broadly neutralizing antibodies, researchers have found the experimental therapy can dramatically reduce the amount of virus present in a patient’s blood.
In the first results to emerge from HIV patient trials of a new generation of so-called broadly neutralizing antibodies, researchers have found the experimental therapy can dramatically reduce the amount of virus present in a patient’s blood.